NanoSomiX and Beckman Coulter Diagnostics Collaborate on Extracellular Vesicle-Enabled Immunoassays for Neurodegenerative Diseases

ALISO VIEJO, Calif., July 22, 2026 /PRNewswire/ -- NanoSomiX, Inc., a biotechnology company focused on blood‑based analytics using extracellular vesicles (EVs), including brain‑derived EVs, today announced plans to collaborate with Beckman Coulter Diagnostics, a global leader in clinical...